calcitriol and Carcinoma--Neuroendocrine

calcitriol has been researched along with Carcinoma--Neuroendocrine* in 1 studies

Other Studies

1 other study(ies) available for calcitriol and Carcinoma--Neuroendocrine

Article	Year
Twist on a classic: vitamin D and hypercalcaemia of malignancy. BMJ case reports, 2017, Nov-23, Volume: 2017 Malignancy is the most common cause of hypercalcaemia in the inpatient setting. Most cases are caused by tumour production of parathyroid hormone-related protein and osseous metastases. In less than 1% of cases, hypercalcaemia is driven by increased production of 1,25-dihydroxyvitamin D (1,25(OH) Topics: Aged; Carcinoma, Neuroendocrine; Female; Humans; Hypercalcemia; Paraneoplastic Syndromes; Uterine Cervical Neoplasms; Vitamin D	2017

Article

Year

Twist on a classic: vitamin D and hypercalcaemia of malignancy.

BMJ case reports, 2017, Nov-23, Volume: 2017

Malignancy is the most common cause of hypercalcaemia in the inpatient setting. Most cases are caused by tumour production of parathyroid hormone-related protein and osseous metastases. In less than 1% of cases, hypercalcaemia is driven by increased production of 1,25-dihydroxyvitamin D (1,25(OH)

Topics: Aged; Carcinoma, Neuroendocrine; Female; Humans; Hypercalcemia; Paraneoplastic Syndromes; Uterine Cervical Neoplasms; Vitamin D

2017